DAPA’s Past-President, Emery Johnson, challenges YOU, our members and participants, to our Scholarship Match Campaign.
He has offered to MATCH up to $500 of donations until the end of February 2022!
This will allow us to have a total of $1000 additional funds for our scholarship winning students!
The Dallas Area Pharmacy Association has been recognizing pharmacy students since 2012, shaping the future of our profession. We are pleased to be able to award scholarships to undergraduates and recent PharmD graduates students that are invested in advocating for their profession and educating their communities.
Your generous gift of any size is a great way to help and encourage our pharmacy students to achieve their goals.
The AbbVie Women’s Health Organization is pleased to connect with the community of Pharmacists in the Dallas area.
We recognize your pharmacies provide services that cover a wide variety of medications, for diverse disease states, patient monitoring, and frequent communications with a diversity of healthcare providers. We as MSLs work to advance R&D in Women’s Health, promoting scientific communications that are fair and balanced and non-promotional in nature. We are here to support all healthcare providers, including pharmacists, deliver the best care to their patients!
Uterine fibroids, also called leiomyomas, are estrogen and progesterone-dependent non-cancerous tumors of the uterus and are the most common type of benign tumor in women of reproductive age. Traditionally, uterine fibroids have been primarily managed by surgery and are the leading reason for the hysterectomies performed in the U.S. ORIAHNN (Elagolix+Estradiol/NETA) is the first FDA-approved non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.
With the ultimate goal to bring awareness, and elevate Women’s healthcare and the scientific acumen of our healthcare givers in our community, I will be offering a virtual educational program to connect with all of you, and provide a brief overview of uterine fibroids disease state and the phase III clinical trial data supporting our newest product indicated for heavy menstrual bleeding associated with uterine fibroids (FDA approved in 2020, https://www.rxabbvie.com/pdf/oriahnn_pi.pdf)
I will be offering two options for you to join via zoom,
Wed Mar 31, at 6 pm CT
Thurs April 1, at 12:30 pm CT
I look forward to having you join!
As your local MSL, please count on me as your local scientific peer and resource.
Thank you for your devoted service to all our patients,
Maria J. Torres, PhD
Medical Science Liaison – Women’s Health | TX MS LA
Women’s Health MSL Organization
US Medical Affairs
BIO: Maria Jose Torres, PhD
Dr. Torres brings 10 years of academic research experience in the Women’s Health arena with a focus on estrogens and estrogen-dependent disease. She completed her bachelor’s degree in Biochemistry in her home country, Uruguay, and then moved to the United States to pursue her Doctorate in Bioenergetics at East Carolina University. Her research work, discovering novel non-genomic mechanisms of metabolic control by estrogens impacted by menopause was published in the top journal Cell, and she was soon recruited to Duke University. Working at the Duke Molecular Physiology Institute, she was a Duke Scholar in Molecular Medicine, she received a Postdoctoral Fellowship through the American Heart Association, and was the developer and leader of a clinical-translational research program to investigate the long-term cardiometabolic toxicity of chemotherapy in breast cancer survivors.
Mission-driven to advance Women’s Health research and healthcare, Dr. Torres recently joined the AbbVie Women’s Health Organization as a Medical Science Liaison, supporting the territory o
DAPA would like to invite you to an upcoming virtual program from Merck Oncology, entitled: Discussing Anti-cancer Therapy Along With Patient Monitoring and Management of Adverse Events.
Below is the speaker presenting for this program.
Dr. Eric Nadler
You will be receiving an email from DAPA with our announcements and updates from DAPA President, Jeff Loesch, before the program.
PROGRAM OVERVIEW: Understand the mechanism of action of a current anticancer therapy Identify what to monitor and how to manage adverse reactions associated with an anticancer therapy Discuss a clinical case highlighting management of selected adverse reactions
Click below to review event dates and to register.
As you click on the link above, you will be able to review the program options and register accordingly. Merck is pleased to sponsor this program. This program is not an accredited CME program and is not designed to meet any training and/or educational requirements.If you have any questions about this event, please email or call me at your convenience. I look forward to speaking with you soon.Regards,Nicole +1 (972) 9745722
Felicia Nicole Joe Merck Customer Representative
Please remember our pharmacy students! We are still supporting our students and are still providing scholarships to students in our community! This meeting is of no charge, but we are still collecting scholarship donations!
DeSoto, TX/DeSoto ISD (September 12, 2019)– Nearly 600 parents and students from elementary school to high school packed DeSoto High School during the district’s College and Career Fair to visit more than 90 colleges, universities, military branches, fraternities, sororities and professional organizations such as DAPA (Dallas Area Pharmacy Association) eager to help connect students to their options after high school.
Our own student liaison, Katherine Chisholm PharmD Candidate Creighton University, has taken the lead in representing pharmacy at the DeSoto High School Career Fair.
She worked with other collaborators in this project to demonstrate to DeSoto high school students what pharmacy is all about!
We want to recognize and thank Katherine Chisholm and all other collaborators that contributed to this project for a wonderful job they have done to shape the future of pharmacy!
You are invited to join the reception honoring Congressman Michael Burges, M.D.
The favor of a reply is requested by contacting Hetaf Kraydi at 202-549-1010 or by email to firstname.lastname@example.org . Please make checks payable to “Michael Burgess for Congress” and mail P.O. Box 15239 Washington, DC 20003